By HealthDay Staff HealthDay Reporter
MONDAY, April 13, 2026 (HealthDay News) — Nearly 12,000 people in the U.K. who received a first dose of the MenB vaccine will now be offered a second shot starting next week, after a deadly meningitis outbreak linked to a university in Kent.
The outbreak led to two deaths and 19 confirmed cases in a short period, according to NHS Kent.
A 21-year-old university student and a younger secondary-school student both died after getting the infection, BBC reported.
Health officials described the situation as "unprecedented" because so many people got sick so quickly.
The vaccination campaign has focused on people who may have been exposed, including:
Students living in dorms
People who visited a nightclub linked to the outbreak
Some additional school and college students
Clinics will open in Canterbury, Faversham and Ashford, and eligible people can book appointments online, BBC reported.
The MenB vaccine requires two doses for full protection.
The second shot is given at least four weeks after the first, though it can be given later.
The vaccine protects against most types of meningococcal group B bacteria in the U.K., BBC said.
The outbreak prompted a national response, with the U.K. Health Security Agency stepping in to support efforts like giving out antibiotics.
Officials are also reviewing whether more teenagers should be offered the MenB vaccine in the future.
More information
The World Health Organization has more on meningitis.
SOURCE: BBC, April 12, 2026
Back
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.
